American Society of Gene & Cell Therapy White Paper

The American Society of Gene & Cell Therapy (ASGCT) is a non-profit medical and scientific professional association comprising 1,700 researchers, clinicians, and students dedicated to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. ASGCT’s strategic vision is to serve as a catalyst for bringing together scientists, physicians, patient advocates, and other stakeholders to transform the practice of medicine by incorporating the use of genetic and cellular therapies to control and cure human disease.

Spotlight

StatRad

Built from the ground up by physicians for physicians, StatRad has been passionately dedicated to providing the very best in patient care while constantly improving our service to our partners through the latest advances in technology. Established in 1996, we partnered with local radiology groups to provide coverage after normal business hours. In 2001, we introduced an innovative teleradiology platform to accelerate transmissions, streamline workflows, increase productivity and improve communication among physicians. Today, we’re maintaining our pioneering spirit by introducing new innovations to the market on a regular basis and providing the technology, expertise and service to help our clients deliver excellent care.

OTHER WHITEPAPERS
news image

BLOCKCHAIN ENABLED GENOME SECURITY FROM THE MOMENT IT IS SEQUENCED

whitePaper | June 8, 2022

Sequencing of human genomes is fast becoming an affordable technology for general consumer.

Read More
news image

BIOPHARMACEUTICAL INDUSTRY AND INTERRELATED BIOTECHNOLOGY ORGANIZATIONS

whitePaper | November 21, 2019

Our Accounting and Finance team has published an overview of the accounting and finance challenges facing the Biopharmaceutical industry and interrelated Biotechnology organizations.

Read More
news image

Transforming cell & gene therapy manufacturing

whitePaper | February 25, 2022

Digitalization and automation promise a better way to streamline the transfer of cell and gene therapies from drug discovery – to commercial production.

Read More
news image

The affordability hurdle for gene therapies

whitePaper | October 12, 2022

Advanced therapy medicinal products cell and gene therapies offer tremendous hope for patients either by actually curing serious diseases or by alleviating suffering.

Read More
news image

Accelerating the Biomanufacturing Revolution

whitePaper | February 11, 2022

The biomanufacturing revolution is here. Recent advancements in the field of synthetic biology have enabled significant cost reductions in foundational bioengineering unit operations such as DNA synthesis and sequencing.

Read More
news image

Vaccine and Biologics Development in an Emerging Post Pandemic Landscape

whitePaper | September 20, 2022

It is clear within the global health science industry that analytical biosafety testing and advances in developing scientific technologies will play an important role in drug development’s response to the next pandemic.

Read More

Spotlight

StatRad

Built from the ground up by physicians for physicians, StatRad has been passionately dedicated to providing the very best in patient care while constantly improving our service to our partners through the latest advances in technology. Established in 1996, we partnered with local radiology groups to provide coverage after normal business hours. In 2001, we introduced an innovative teleradiology platform to accelerate transmissions, streamline workflows, increase productivity and improve communication among physicians. Today, we’re maintaining our pioneering spirit by introducing new innovations to the market on a regular basis and providing the technology, expertise and service to help our clients deliver excellent care.

Events